The effect of unfractionated heparin, enoxaparin, and danaparoid on lupus anticoagulant testing: Can activated carbon eliminate false‐positive results?

by Pieter M.M. De Kesel, Katrien M.J. Devreese
Published 2020-01-01

Influence of anticardiolipin and anti‐β2 glycoprotein I antibody cutoff values on antiphospholipid syndrome classification

by Laura Vanoverschelde, Hilde Kelchtermans, Jacek Musial, Bas de Laat, Katrien M. J. Devreese
Published 2019-07-01

Active von Willebrand Factor in patients with a bleeding diathesis

by Lisa N. van der Vorm, Dana Huskens, Lisa Florin, Pieter De Kesel, Mark Roest, Bas de Laat, Katrien M.J. Devreese
Published 2020-12-01

Belgian rare diseases plan in clinical pathology: identification of key biochemical diagnostic tests and establishment of reference laboratories and financing conditions

by Nathalie M. Vandevelde, Pieter Vermeersch, Katrien M. J. Devreese, Marie-Françoise Vincent, Béatrice Gulbis, François Eyskens, François Boemer, André Gothot, Viviane O. Van Hoof, Carolien Bonroy, Hedwig Stepman, Geert A. Martens, Xavier Bossuyt, Laurence Roosens, Julie Smet, Hilde Laeremans, Ilse Weets, Jean-Marc Minon, Kris Vernelen, Wim Coucke, Advisory Board of the Action 1 of the Belgian National Plan for Rare Diseases
Published 2021-02-01